Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05083416 · ClinicalTrials.gov registry record · NA
Effect of Prolonged Nightly Fasting on Immunotherapy Outcomes in HNSCC - Role of Gut Microbiome
A NA study, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 29
- Enrollment target
NCT05083416 is a NA study that has completed, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 29 participants.
The verdict
NCT05083416, a NA study, has completed, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 29 participants
- Enrollment target
Study Summary
This study aims to evaluate if eating within an 8-10-hour window during the day, without any caloric restriction, can lead to better response rates to immunotherapy in head and neck cancer patients.
Interventions
- BEHAVIORAL Prolonged Nightly Fasting
- BEHAVIORAL Regular Eating pattern
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2021-10-20 |
| Est. Completion | 2024-02-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05083416
The ClinicalTrials.gov registry entry for NCT05083416 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is H. Lee Moffitt Cancer Center and Research Institute, which has 502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Prolonged Nightly Fasting is the first listed.
NCT05083416 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05083416 about?
NCT05083416 is a clinical study titled "Effect of Prolonged Nightly Fasting on Immunotherapy Outcomes in HNSCC - Role of Gut Microbiome". This study aims to evaluate if eating within an 8-10-hour window during the day, without any caloric restriction, can lead to better response rates to immunotherapy in head and neck cancer patients.
What is the current status of trial NCT05083416?
This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2021-10-20. Estimated completion is 2024-02-08.
What interventions are being tested in trial NCT05083416?
The interventions under investigation include: Prolonged Nightly Fasting (BEHAVIORAL), Regular Eating pattern (BEHAVIORAL).
Who is sponsoring clinical trial NCT05083416?
This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.